OpenLegislation

Division Circumstances in which required

United Kingdom

Original text. Later amendments are not shown.

The acute dermal toxicity of the active substance shall be reported unless waiving is scientifically justified (for example where oral LD50f1 is greater than 2 000 mg/kg). Both local and systemic effects shall be investigated.

Findings of severe skin irritation (Grade 4 erythema or oedema) in the dermal study shall be used instead of performing a specific irritation study.

Annotations

Footnotes

f1

LD50, abbreviation for ‘Lethal Dose, 50 %’, that is to say the dose required to kill half the members of a tested population after a specified test duration.

Notes on Division 5.2

Footnotes

f1

aAOEL, abbreviation for ‘Acute AOEL’.